JP2022517399A5 - - Google Patents

Info

Publication number
JP2022517399A5
JP2022517399A5 JP2021541187A JP2021541187A JP2022517399A5 JP 2022517399 A5 JP2022517399 A5 JP 2022517399A5 JP 2021541187 A JP2021541187 A JP 2021541187A JP 2021541187 A JP2021541187 A JP 2021541187A JP 2022517399 A5 JP2022517399 A5 JP 2022517399A5
Authority
JP
Japan
Application number
JP2021541187A
Other languages
Japanese (ja)
Other versions
JP2022517399A (ja
JPWO2020148530A5 (https=
Filing date
Publication date
Priority claimed from GBGB1900530.5A external-priority patent/GB201900530D0/en
Application filed filed Critical
Publication of JP2022517399A publication Critical patent/JP2022517399A/ja
Publication of JP2022517399A5 publication Critical patent/JP2022517399A5/ja
Publication of JPWO2020148530A5 publication Critical patent/JPWO2020148530A5/ja
Pending legal-status Critical Current

Links

JP2021541187A 2019-01-15 2020-01-15 Cd38に特異的な二環式ペプチドリガンド Pending JP2022517399A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1900530.5 2019-01-15
GBGB1900530.5A GB201900530D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for CD38
PCT/GB2020/050074 WO2020148530A1 (en) 2019-01-15 2020-01-15 Bicyclic peptide ligands specific for cd38

Publications (3)

Publication Number Publication Date
JP2022517399A JP2022517399A (ja) 2022-03-08
JP2022517399A5 true JP2022517399A5 (https=) 2023-01-25
JPWO2020148530A5 JPWO2020148530A5 (https=) 2023-01-25

Family

ID=65528178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021541187A Pending JP2022517399A (ja) 2019-01-15 2020-01-15 Cd38に特異的な二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220133733A1 (https=)
EP (1) EP3911366A1 (https=)
JP (1) JP2022517399A (https=)
CN (1) CN113597317A (https=)
GB (1) GB201900530D0 (https=)
WO (1) WO2020148530A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
JP7301757B2 (ja) 2017-06-26 2023-07-03 バイスクルアールディー・リミテッド 検出可能部分を持つ二環式ペプチドリガンドおよびその使用
CN111183147B (zh) 2017-08-04 2024-07-05 拜斯科技术开发有限公司 Cd137特异性的双环肽配体
JP2021514953A (ja) 2018-02-23 2021-06-17 バイスクルテクス・リミテッド 多量体二環式ペプチドリガンド
IL279489B2 (en) 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
US12551567B2 (en) 2018-12-21 2026-02-17 Bicyclerd Limited Bicyclic peptide ligands specific for PD-L1
JP2022514618A (ja) 2018-12-21 2022-02-14 バイスクルテクス・リミテッド Pd-l1に特異的な二環式ペプチドリガンド
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
IL300248A (en) 2020-08-03 2023-03-01 Bicycletx Ltd peptide-based linkers
GB202016331D0 (en) * 2020-10-15 2020-12-02 Bicyclerd Ltd Bicyclic peptide ligand drug conjugates
CN118388598A (zh) * 2024-04-22 2024-07-26 苏州大学附属第一医院 标记前体、探针及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006514104A (ja) * 2002-12-12 2006-04-27 テル アヴィヴ ユニヴァーシティ フューチャー テクノロジー ディヴェロップメント エル.ピー. グリコーゲンシンターゼキナーゼ−3阻害剤
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
DK2511297T3 (en) 2004-02-06 2015-06-15 Morphosys Ag Human anti-CD38 antibodies and their applications
DK1844337T3 (da) 2005-01-24 2013-09-30 Pepscan Systems Bv Bindingsforbindelser, immunogene forbindelser og peptidmimetika
EP2567976B1 (en) * 2005-03-23 2017-07-19 Genmab A/S Antibodies against CD38 for treatment of multiple myeloma
AU2009211253B2 (en) 2008-02-05 2014-11-06 Bicyclerd Limited Methods and compositions
EP3613426A1 (en) * 2014-05-21 2020-02-26 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
JP2018521960A (ja) * 2015-04-28 2018-08-09 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ(ウペエフエル)Ecole Polytechnique Federale de Lausanne (EPFL) 酵素で活性化された第XII因子(FXIIa)の新規阻害剤
JP7301757B2 (ja) * 2017-06-26 2023-07-03 バイスクルアールディー・リミテッド 検出可能部分を持つ二環式ペプチドリガンドおよびその使用
GB201810320D0 (en) * 2018-06-22 2018-08-08 Bicycletx Ltd Peptide ligands for binding to CD38

Similar Documents

Publication Publication Date Title
JP2022517399A5 (https=)
JP2022517040A5 (https=)
CL2025002820A1 (es) Interfaz radial y axial entre barra conductora y máquina de trabajo.
CN306127535S (https=)
CN305633218S (https=)
CN305807129S (https=)
CN305534658S (https=)
CN305534157S (https=)
CN305803418S (https=)
CN305530979S (https=)
CN305851983S (https=)
CN305802719S (https=)
CN305530559S (https=)
CN305530312S (https=)
CN305830033S (https=)
CN305792165S (https=)
CN305530122S (https=)
CN305530023S (https=)
CN305858410S (https=)
CN306106674S (https=)
CN305529256S (https=)
CN306270009S (https=)
CN305868902S (https=)
CN306267764S (https=)
CN306257527S (https=)